PROCEPT BioRobotics Corp (PRCT)
68.81
+0.11
(+0.16%)
USD |
NASDAQ |
May 21, 12:51
PROCEPT BioRobotics Cash from Operations (Quarterly): -32.29M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -32.29M |
| December 31, 2023 | -24.79M |
| September 30, 2023 | -18.94M |
| June 30, 2023 | -28.34M |
| March 31, 2023 | -35.93M |
| December 31, 2022 | -25.17M |
| September 30, 2022 | -19.85M |
| Date | Value |
|---|---|
| June 30, 2022 | -17.13M |
| March 31, 2022 | -18.23M |
| December 31, 2021 | -16.48M |
| September 30, 2021 | -12.75M |
| June 30, 2021 | -12.91M |
| March 31, 2021 | -15.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.93M
Minimum
Mar 2023
-12.75M
Maximum
Sep 2021
-21.38M
Average
-18.94M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| Intuitive Surgical Inc | 265.40M |
| Integra Lifesciences Holdings Corp | 15.76M |
| Masimo Corp | 45.80M |
| Perspective Therapeutics Inc | 13.85M |
| Xtant Medical Holdings Inc | -5.755M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.946M |
| Cash from Financing (Quarterly) | 2.586M |
| Free Cash Flow | -126.17M |
| Free Cash Flow Per Share (Quarterly) | -0.6711 |
| Free Cash Flow to Equity (Quarterly) | -34.26M |
| Free Cash Flow Yield | -3.76% |